Product Description
Experience elite and unparalleled immunosuppression with IMMUTIL 500 MG Tablet, tailored exclusively for superior transplant care. Engineered with the fresh potency of Mycophenolate Mofetil, IMMUTIL, generic to CellCept, guarantees superlative efficacy in protecting renal, cardiac, and hepatic transplant patients. With IP regulatory approval and a pristine white tablet form, IMMUTIL provides exceptional savings through reliable protection and longevity-spanning up to 24 months. Each box contains 100 precisely dosed tablets (10x1x10 blister packs), ensuring you never compromise on safeguard or quality. Prescription required for use.
Optimal Use in Transplant Management
IMMUTIL 500 MG Tablet is specifically crafted for adult patients undergoing kidney, liver, or heart transplants. Its clinical application as an immunosuppressant ensures superior protection against organ rejection. It is widely recommended for use by transplant recipients, under the strict supervision and dosage guidance of a physician. Renowned for its targeted therapeutic action, IMMUTIL addresses critical needs in renal, cardiac, and hepatic transplantation procedures, fostering confidence and reliability in post-operative care.
Payment Terms and Global Reach
IMMUTIL 500 MG Tablet offers competitive rates with a focus on cost-efficient outlays for bulk supply. The handover of products is timely and secure, meeting export standards for quality. IMMUTIL is actively exported to main markets worldwide, packaged in 100-tablet boxes (10 blister packs) to ensure freshness and integrity. Secure packaging and adherence to global logistics make IMMUTIL a trusted choice for healthcare providers and distributors seeking uncompromised product outlay.
FAQ's of IMMUTIL 500 MG Tablet:
Q: How should IMMUTIL 500 MG Tablet be used for transplant patients?
A: IMMUTIL 500 MG Tablet must be taken exactly as prescribed by your physician, typically after a kidney, liver, or heart transplant to help prevent organ rejection. Dosage and duration are determined by the treating doctor.
Q: What is the primary benefit of IMMUTIL 500 MG Tablet?
A: The primary benefit of IMMUTIL 500 MG Tablet lies in its superior immunosuppressant action, reducing the risk of transplant rejection and enabling improved long-term health outcomes for transplant patients.
Q: When should I start taking IMMUTIL post-transplant?
A: IMMUTIL 500 MG Tablet is generally started immediately after the transplant procedure, as per your physician's guidance, to maximize its effectiveness in preventing immune-mediated organ rejection.
Q: Where is IMMUTIL 500 MG Tablet manufactured and exported from?
A: IMMUTIL 500 MG Tablet is manufactured and exported from India, complying with rigorous IP standards for safety, efficacy, and regulatory approval.
Q: What is the storage guideline for IMMUTIL 500 MG Tablet?
A: IMMUTIL 500 MG Tablets should be stored in a cool, dry place to maintain their potency and freshness over their 24-month shelf life. Always check the pack for the exact expiry date before use.
Q: What packaging format is offered for IMMUTIL 500 MG Tablet?
A: IMMUTIL 500 MG Tablet is provided in 100-tablet boxes, with each box containing 10 blister packs of 10 tablets, ensuring easy handling and secure storage during transport and use.
Send Inquiry
Send Inquiry
Send SMS
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese